Glyxambi (empagliflozin and linagliptin) is a medicine used alongside diet and exercise to lower blood sugar in adults with type 2 diabetes mellitus. It combines two active ingredients to reduce sugar levels when treatment with both is appropriate, often used when metformin or other treatments are insufficient.
